Trials / Completed
CompletedNCT00309530
Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C
A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 598 (planned)
- Sponsor
- Austrian Breast & Colorectal Cancer Study Group · Network
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This clinical investigation examined the effectivity 5-fluorouracil, of adding levamisol or interferon to 5-fluorouracil, and of a 5-fluorouracil/levamisol/interferon triple combination, in terms of recurrence-free and overall survival in curatively operable colon carcinoma Stage III.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5-fluorouracil, levamisol, interferon |
Timeline
- Start date
- 1990-10-01
- First posted
- 2006-04-03
- Last updated
- 2006-04-03
Locations
16 sites across 1 country: Austria
Source: ClinicalTrials.gov record NCT00309530. Inclusion in this directory is not an endorsement.